Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ALBO | Common Stock | Sale | -$3.07K | -90 | -0.72% | $34.13 | 12.5K | Jul 22, 2021 | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Shares sold pursuant to a Rule 10b5-1 arrangement established in October 2019 to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. |
F2 | Represents 5,075 shares of common stock and 7,375 restricted stock units. Includes 647 shares of common stock acquired under the Albireo Pharma, Inc. 2018 Employee Stock Purchase Plan (the "ESPP") on May 31, 2021. |